Articles published by GlobeNewswire
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4634ed44-6fe0-478f-afcb-02c13ea6aa1f/small/untitled-design-png.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/d2158bfd-0e66-4505-afd4-86dd7d0f2dc1/small/logo-2-jpg.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3f4ab307-5947-4ef1-b5b5-c2c66933728a/small/aptose-biosciences-inc-logo.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 19, 2024
Via GlobeNewswire
Tickers
IOVA
![](https://ml.globenewswire.com/media/c7f8f32b-7ac6-44fb-a127-8110d0b2c632/small/monroe-capital-logo-cmyk-1-jpg.jpg)
Monroe Capital Corporation Schedules Second Quarter 2024 Earnings Release and Conference Call
July 19, 2024
Via GlobeNewswire
Tickers
MRCC
![](https://ml.globenewswire.com/media/5115f449-412d-4a05-bbcb-add09b3f2838/small/blank-logo-png.png)
![](https://ml-eu.globenewswire.com/media/3e934184-5c25-44fd-880b-e10deb63e6e1/small/edap-tms-rgb-300dpi-20160111-png.png)
![](https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png)
Via GlobeNewswire
Tickers
RARE
![](https://www.globenewswire.com/Content/Images/intrado.png)
Meta Data Limited Announces Planned ADS Ratio Change
July 19, 2024
From Meta Data Limited
Via GlobeNewswire
Tickers
AIU
![](https://ml.globenewswire.com/media/b3e3f449-85d4-4bed-994a-3e447b0c5440/small/remitly-jpg.jpg)
![](https://ml.globenewswire.com/media/9b6f658a-4f93-4844-bff6-a0d8b1a855a9/small/cumulus-logo-png.png)
Cumulus Media Announces Conference Call to Discuss Second Quarter 2024 Operating Results
July 19, 2024
From Cumulus Media Inc.
Via GlobeNewswire
Tickers
CMLS
![](https://ml.globenewswire.com/media/5d514042-8326-4555-8ad7-f6cc765ecfcd/small/bl-new-logo-jpg.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://ml.globenewswire.com/media/a28f0d0c-70ab-4d69-a30d-aaaf5bd42745/small/fireswarm-notified-logo-on-yellow-horizontal-tm-png.png)
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.